Trang chủSÁCH DỊCH TIẾNG VIỆTSách Dịch - Y học Chu Phẫu 2E

[Sách Dịch] Y học Chu phẫu. Chương 35. Ghép Tạng Đặc

206
[Sách Dịch] Y học Chu phẫu. Chương 20. Phòng ngừa và Điều trị Biến chứng Phổi Hậu phẫu
Nhiễm trùng liên quan đến chăm sóc y tế (HAIs)
Sách dịch. Các nguyên lý Y học Hô hấp 8e. CHƯƠNG 22. Các Cơ chế Phòng vệ của Phổi

  1. Wijdicks E.F.M.: The transatlantic divide over brain death determination and the debate. Brain 2012; 135: pp. 1321-1331.
  2. Punch J.D., Hayes D.H., LaPorte F.B., et. al.: Organ donation and utilization in the United States, 1996–2005. Am J Transplant 2007; 7: pp. 1327-1338.
  3. Skaro A.I., Jay C.L., Ladner D., et. al.: Trends in donation after cardiac death and donation after brain death—reading between the lines. Am J Transplant 2010; 10: pp. 2390-2391.
  4. Reese P.P., Boudville N., Garg A.X.: Living kidney donation: Outcomes, ethics, and uncertainty. Lancet 2015; 385: pp. 2003-2013.
  5. Sugawara Y., Makuuchi M.: Living donor liver transplantation: Present status and recent advances. Br Med Bull 2005; 75-76: pp. 15-28.
  6. Kim P.T.W., Testa G.: Living donor liver transplantation in the USA. Hepatobiliary Surg Nutr 2016; 5: pp. 133-140.
  7. Allison T.L.: Immunosuppressive therapy in transplantation. Nurs Clin North Am 2016; 51: pp. 107-120.
  8. Meirelles R.F., Salvalaggio P., de Rezende M.B., et. al.: Liver transplantation: History, outcomes and perspectives. Einstein (Sao Paulo) 2015; 13: pp. 149-152.
  9. Wong RJ, Aguilar M, Cheung R, et al: Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology. 148(3):547-555.
  10. Malinchoc M., Kamath P.S., Gordon F.D., et. al.: A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: pp. 864-871.
  11. Lopez-Delgado J.C., Ballus J., Esteve F., et. al.: Outcomes of abdominal surgery in patients with liver cirrhosis. World J Gastroenterol 2016; 22: pp. 2657-2667.
  12. McGuire B.M., Bloomer J.R.: Complications of cirrhosis. Why they occur and what to do about them. Postgrad Med 1998; 103: pp. 209-224.
  13. Strasberg S.M., Howard T.K., Molmenti E.P., et. al.: Selecting the donor liver: Risk factors for poor function after orthotopic liver transplantation. Hepatology 1994; 20: pp. 829-838.
  14. O’Neill S., Roebuck A., Khoo E., et. al.: A meta-analysis and meta-regression of outcomes including biliary complications in donation after cardiac death liver transplantation. Transpl Int 2014; 27: pp. 1159-1174.
  15. Gruenberger T., Steininger R., Sautner T., et. al.: Influence of donor criteria on postoperative graft function after orthotopic liver transplantation. Transpl Int 1994; 7: pp. 672-674.
  16. Trotter J.F.: Challenges in living donor liver transplantation. Clin Liver Dis 2014; 18: pp. 651-660.
  17. Pinson C.W.: Medical care of the liver transplant patient. Ann Surg 1999; 229: pp. 440-441.
  18. de Bruijn S., Philipse E., Couttenye M.M., et. al.: Passenger Lymphocyte Syndrome (PLS): A single-center retrospective analysis of minor ABO-incompatible liver transplants. J Clin Transl Hepatol 2017; 5: pp. 9-15.
  19. Wolfe R.A., Ashby V.B., Milford E.L., et. al.: Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: pp. 1725-1730.
  20. Bunnapradist S., Danovitch G.M.: Evaluation of adult kidney transplant candidates. Am J Kidney Dis 2007; 50: pp. 890-989.
  21. Danovitch G.M.: Handbook of Kidney Transplantation.2017.Philadelphia: Lippincott Williams & Wilkins
  22. Rao P.S., Schaubel D.E., Guidinger M.K., et. al.: A comprehensive risk quantification score for deceased donor kidneys: The kidney donor risk index. Transplantation 2009; 88: pp. 231-236.
  23. Reese P.P., Boudville N., Garg A.X.: Living kidney donation: Outcomes, ethics, and uncertainty. Lancet 2015; 385: pp. 2003-2013.
  24. Shoskes D.A.: Deleterious effects of delayed graft function in cadaveric renal transplant recipients independent of acute rejection. Transplantation 1998; 66: pp. 1697-1701.
  25. Shoskes D.A., Hodge E.E., Goormastic M., et. al.: HLA matching determines susceptibility to harmful effects of delayed graft function in renal transplant recipients. Transplant Proc 1995; 27: pp. 1068-1069.
  26. Mackenzie H.S., Azuma H., Rennke H.G., et. al.: Renal mass as a determinant of late allograft outcome: Insights from experimental studies in rats. Kidney Int Suppl 1995; 52: pp. S38-S42.
  27. Squifflet J.P., Gruessner R.W., Sutherland D.E.: The history of pancreas transplantation: past, present and future. Acta Chir Belg 2008; 108: pp. 367-378.
  28. Smith J.M., Biggins S.W., Haselby D.G., et. al.: Kidney, pancreas and liver allocation and distribution in the United States. Am J Transplant 2012; 12: pp. 3191-3212.
  29. Zaman F., Abreo K.D., Levine S., et. al.: Pancreatic transplantation: Evaluation and management. J Intensive Care Med 2004; 19: pp. 127-139.
  30. Meirelles R.F., Salvalaggio P., Pacheco-Silva A.: Pancreas transplantation: Review. Einstein 2015; 13: pp. 305-309.
  31. Deltz E., Mengel W., Hamelmann H.: Small bowel transplantation: Report of a clinical case. Prog Pediatr Surg 1990; 25: pp. 90-96.
  32. Grant D., Wall W., Mimeault R., et. al.: Successful small-bowel/liver transplantation. Lancet 1990; 335: pp. 181-184.
  33. Tzakis A.G., Todo S., Starzl T.E.: Intestinal transplantation. Annu Rev Med 1994; 45: pp. 79-91.
  34. Rawal N., Yazigi N.: Intestinal transplant in children. Pediatr Clin North Am 2017; 64: pp. 613-619.
  35. Nguyen-Buckley C., Wong M.: Anesthesia for intestinal transplantation. Anesthesiol Clin 2017; 35: pp. 509-521.
  36. Gürkan A.: Advances in small bowel transplantation. Turk J Surg 2017; 33: pp. 135-141.
  37. Reyes J.D.: Intestinal transplantation. Semin Pediatr Surg 2006; 15: pp. 228-234.
  38. Soltys K.A., Bond G., Sindhi R., et. al.: Pediatric intestinal transplantation. Semin Pediatr Surg 2017; 26: pp. 241-249.
  39. Vega J.D., Moore J., Murray S., et. al.: Heart transplantation in the United States, 1998-2007. Am J Transplant 2009; 9: pp. 932-941.
  40. Lund L.H., Edwards L.B., Kucheryavaya A.Y., et. al.: The Registry of the International Society for Heart and Lung Transplantation: Thirtieth Official Adult Heart Transplant Report–2013; Focus theme: Age. J Heart Lung Transplant 2013; 32: pp. 951-964.
  41. Jhund P.S., Macintyre K., Simpson C.R., et. al.: Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: A population study of 5.1 million people. Circulation 2009; 119: pp. 515-523.
  42. Ammirati E., Rimoldi O.E., Camici P.G.: Is there evidence supporting coronary revascularization in patients with left ventricular systolic dysfunction?. Circ J 2011; 75: pp. 3-10.
  43. Velazquez E.J., Lee K.L., Deja M.A., et. al.: Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med 2011; 364: pp. 1607-1616.
  44. Jones R.H., Velazquez E.J., Michler R.E., et. al.: Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med 2009; 360: pp. 1705-1717.
  45. Deja M.A., Grayburn P.A., Sun B., et. al.: Influence of mitral regurgitation repair on survival in the surgical treatment for ischemic heart failure trial. Circulation 2012; 125: pp. 2639-2648.
  46. McMurray J.J., Adamopoulos S., Anker S.D., et. al.: ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012; 14: pp. 803-869.
  47. Mebazaa A., Nieminen M.S., Packer M., et. al.: Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial. JAMA 2007; 297: pp. 1883-1891.
  48. Oliva F., Mortara A., Cacciatore G., et. al.: Acute heart failure patient profiles, management and in-hospital outcome: Results of the Italian Registry on Heart Failure Outcome. Eur J Heart Fail 2012; 14: pp. 1208-1217.
  49. Tavazzi L., Maggioni A.P., Lucci D., et. al.: Nationwide survey on acute heart failure in cardiology ward services in Italy. Eur Heart J 2006; 27: pp. 1207-1215.
  50. Metra M., Ponikowski P., Dickstein K., et. al.: Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2007; 9: pp. 684-694.
  51. Zaroff J.G., Rosengard B.R., Armstrong W.F., et. al.: Consensus conference report: maximizing use of organs recovered from the cadaver donor: Cardiac recommendations, March 28-29, 2001, Crystal City, Va. Circulation 2002; 106: pp. 836-841.
  52. Stecker E.C., Strelich K.R., Chugh S.S., et. al.: Arrhythmias after orthotopic heart transplantation. J Card Fail 2005; 11: pp. 464-472.
  53. Tischler M.D., Lee R.T., Plappert T., et. al.: Serial assessment of left ventricular function and mass after orthotopic heart transplantation: A 4-year longitudinal study. J Am Coll Cardiol 1992; 19: pp. 60-66.
  54. Gerber B.L., Bernard X., Melin J.A., et. al.: Exaggerated chronotropic and energetic response to dobutamine after orthotopic cardiac transplantation. J Heart Lung Transplant 2001; 20: pp. 824-832.
  55. Kirklin J.K., Naftel D.C., Bourge R.C., et. al.: Evolving trends in risk profiles and causes of death after heart transplantation: A ten-year multi-institutional study. J Thorac Cardiovasc Surg 2003; 125: pp. 881-890.
  56. Minev P.A., El-Banayosy A., Minami K., et. al.: Differential indication for mechanical circulatory support following heart transplantation. Intensive Care Med 2001; 27: pp. 1321-1327.
  57. Srivastava R., Keck B.M., Bennett L.E., et. al.: The results of cardiac retransplantation: an analysis of the Joint International Society for Heart and Lung Transplantation/United Network for Organ Sharing Thoracic Registry. Transplantation 2000; 70: pp. 606-612.
  58. Kieler-Jensen N., Lundin S., Ricksten S.E.: Vasodilator therapy after heart transplantation: Effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside. J Heart Lung Transplant 1995; 14: pp. 436-443.
  59. Arafa O.E., Geiran O.R., Andersen K., et. al.: Intraaortic balloon pumping for predominantly right ventricular failure after heart transplantation. Ann Thorac Surg 2000; 70: pp. 1587-1593.
  60. Miller L.W.: Treatment of cardiac allograft rejection with intravenous corticosteroids. J Heart Transplant 1990; 9: pp. 283-287. Pt 2
  61. Sharples L.D., Caine N., Mullins P., et. al.: Risk factor analysis for the major hazards following heart transplantation—rejection, infection, and coronary occlusive disease. Transplantation 1991; 52: pp. 244-252.
  62. Horwitz P.A., Tsai E.J., Putt M.E., et. al.: Detection of cardiac allograft rejection and response to immunosuppressive therapy with peripheral blood gene expression. Circulation 2004; 110: pp. 3815-3821.
  63. Chen Y., Zhang H., Xiao X., et. al.: Peripheral blood transcriptome sequencing reveals rejection-relevant genes in long-term heart transplantation. Int J Cardiol 2013; 168: pp. 2726-2733.
  64. Pham M.X., Teuteberg J.J., Kfoury A.G., et. al.: Gene-expression profiling for rejection surveillance after cardiac transplantation. N Engl J Med 2010; 362: pp. 1890-1900.
  65. Venuta F., Van Raemdonck D.: History of lung transplantation. J Thorac Dis 2017; 9: pp. 5458-5471.
  66. Pierson 3rd, Barr M.L., McCullough K.P., et. al.: Thoracic organ transplantation. Am J Transplant 2004; 4: pp. 93-105.
  67. Gottlieb J.: Lung allocation. J Thorac Dis. 2017; 9: pp. 2670-2674.

67a. Nathan S.D.: Lung transplantation: Disease-specific considerations for referral. Chest 2005; 127: pp. 1006-1016.

  1. Yeung J.C., Keshavjee S.: Overview of clinical lung transplantation. Cold Spring Harb Perspect Med 2014; 4: pp. a015628.
  2. Snell G.I., Paraskeva M., Westall G.P.: Donor selection and management. Semin Respir Crit Care Med 2013; 34: pp. 361-370.
  3. Baez B., Castillo M.: Anesthetic considerations for lung transplantation. Semin Cardiothorac Vasc Anesth 2008; 12: pp. 122-127.
  4. Rosenberg A.L., Rao M., Benedict P.E.: Anesthetic implications for lung transplantation. Anesthesiol Clin North Am 2004; 22: pp. 767-788.
  5. Brower R.G., Lanken P.N., MacIntyre N., et. al.: Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 2004; 351: pp. 327-336.
  6. Goudarzi B.M., Bonvino S.: Critical care issues in lung and heart transplantation. Crit Care Clin 2003; 19: pp. 209-231.
  7. Leal S., Sacanell J., Riera J., et. al.: Early postoperative management of lung transplantation. Minerva Anestesiol 2014; 80: pp. 1234-1245.
  8. Wang E.H., Partovi N., Levy R.D., et. al.: Pneumocystis pneumonia in solid organ transplant recipients: Not yet an infection of the past. Transpl Infect Dis 2012; 14: pp. 519-525.
  9. Chapman J.R., Marriott D.J., Chen S.C.A., et. al.: Post-transplant Pneumocystis jirovecii pneumonia—a re-emerged public health problem?. Kidney Int 2013; 84: pp. 240-243.
  10. Derouin F., Pelloux H.: Prevention of toxoplasmosis in transplant patients. Clin Microbiol Infect 2008; 14: pp. 1089-1101.
  11. Brizendine K.D., Vishin S., Baddley J.W.: Antifungal prophylaxis in solid organ transplant recipients. Expert Rev Anti Infect Ther 2011; 9: pp. 571-581.
  12. Potena L., Solidoro P., Patrucco F., et. al.: Treatment and prevention of cytomegalovirus infection in heart and lung transplantation: An update. Expert Opin Pharmacother 2016; 17: pp. 1611-1622.
  13. Durand C.M., Bowring M.G., Brown D.M., et. al.: Direct-acting antiviral prophylaxis in kidney transplantation from hepatitis C virus-infected donors to noninfected recipients: an open-label nonrandomized trial. Ann Intern Med 2018; 168: pp. 533-540.
  14. Slifkin M., Doron S., Snydman D.R.: Viral prophylaxis in organ transplant patients. Drugs 2004; 64: pp. 2763-2792.

 

TRANG

1 2

ĐỀ XUẤT CHO BẠN

Đang tải...